Trial Profile
Clinical Pharmacology Study of TS-143 in Hemodialysis and Non-dialysis Chronic Kidney Disease Patients
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs BGE 117 (Primary)
- Indications Renal failure
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Taisho Pharmaceutical
- 08 Sep 2017 Status changed from recruiting to completed.
- 03 Oct 2016 New trial record